Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group.

× No keyword cloud information.

4 in total

1. Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component.

Authors: C Greco; F Ameglio; F Alvino; A Mosiello; A M Cianciulli; I Venturo; G Del Monte; M Giampaolo; A W Tong; G M Gandolfo
Journal: Cell Prolif Date: 1999-08 Impact factor: 6.831

2. Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.

Authors: Güllü Görgün; Elisabetta Calabrese; Ender Soydan; Teru Hideshima; Giulia Perrone; Madhavi Bandi; Diana Cirstea; Loredana Santo; Yiguo Hu; Yu-Tzu Tai; Sabikun Nahar; Naoya Mimura; Claire Fabre; Noopur Raje; Nikhil Munshi; Paul Richardson; Kenneth C Anderson
Journal: Blood Date: 2010-07-22 Impact factor: 22.113

3. Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1).

Authors: D M Menke; H P Horny; H Griesser; E J Atkinson; E Kaiserling; R A Kyle
Journal: J Clin Pathol Date: 1998-06 Impact factor: 3.411

4. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications.

Authors: R Luque; J A Brieva; A Moreno; A Manzanal; L Escribano; J Villarrubia; J L Velasco; J López-Jiménez; C Cerveró; M J Otero; J Martínez; C Bellas; E Roldán
Journal: Clin Exp Immunol Date: 1998-06 Impact factor: 4.330

4 in total